Anyone who works regularly with lyophilised research peptides knows the problem: a peptide that according to the certificate should be perfectly soluble still turns cloudy in a particular buffer, or precipitates after a few hours. Often the explanation lies not with the purity of the sample, but with a property that receives too little attention in laboratory protocols: the isoelectric point (pI) of the peptide sequence. This article discusses what the pI actually is, why it determines the solubility and aggregation tendency of a peptide, and how researchers can use this information when designing experiments.
What is the isoelectric point of a peptide?
The isoelectric point is the pH value at which a peptide carries no net electrical charge. Below that pH the net charge is positive, because basic side chains (for example of lysine, arginine or histidine) are protonated; above that pH the negative charge of acidic residues such as aspartic acid and glutamic acid dominates, together with the free carboxyl and amino termini. The pI is determined by the complete amino acid composition and sequence of the peptide, and can be estimated with existing calculation models on the basis of the pKa values of the side chains present.
Why net charge governs solubility
A peptide with a strong net charge — positive or negative — repels itself electrostatically in solution. That mutual repulsion keeps individual peptide molecules apart and promotes solubility. Around the pI, however, that repulsive force largely disappears: the net charge is zero, so hydrophobic interactions and hydrogen bonds between peptide molecules become relatively stronger. That is precisely the point at which precipitation or aggregation is most likely. For researchers this means that a buffer choice bringing the pH of a solution close to the pI of the peptide sequence carries an increased risk of precipitation, regardless of how pure the starting material is.
Aggregation is more than precipitation alone
Visible cloudiness is the most obvious expression of aggregation, but not the only one. Peptides with a pronounced hydrophobic character can, at pH values around their pI, also form oligomers or ordered structures that are not visible to the naked eye but do lower the effective concentration of monomeric peptide in a sample. Published research on amyloid-forming peptide sequences shows, for example, that the interplay between pH, net charge and hydrophobicity determines the folding and aggregation route a peptide follows. For quantitative analyses — such as determinations via UV-Vis or AAA — this is relevant: a sample that has partly aggregated does not necessarily give a representative measurement of the actual peptide concentration.
Estimating the pI before setting up an experiment
For most standard sequences a rough estimate of the pI can be made with freely available calculation tools that take the amino acid composition as input. For modified peptides — with an acetylated N-terminus, an amidated C-terminus, or non-natural amino acids — extra caution is warranted, because standard models do not always account for these modifications correctly. In that case it is advisable to combine the pI estimate with a simple solubility test: reconstitute a small quantity of peptide in the intended buffer and check the solution visually for cloudiness over a few hours, before setting up the full experiment.
Practical implications for buffer choice
Once the estimated pI of a sequence is known, the pH of the working buffer can be chosen deliberately in relation to it. As a general rule of thumb, a pH at least one to two units away from the pI usually yields a greater net charge and therefore a more stable solution than a pH close to it. For peptides with a low pI (predominantly acidic sequences) this often means a slightly basic buffer works out better, while basic sequences with a high pI can benefit from a slightly acidic buffer. This consideration is separate from other factors influencing buffer choice, such as compatibility with a downstream analytical technique, and so serves as an additional rather than a replacement criterion.
The products and information of Dutch Peptide Labs are intended solely for laboratory and research purposes. They are not intended for human or animal consumption, diagnostic use or therapeutic application.
